Ignite Creation Date:
2024-05-05 @ 5:20 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00436826
Status:
COMPLETED
Last Update Posted:
2020-10-12
First Post:
2007-02-15
Brief Title:
A Phase 2 Study of Cladribine Add-on to Interferon-beta IFN-beta Therapy in Multiple Sclerosis MS Subjects With Active Disease ONWARD
Sponsor:
EMD Serono Research Development Institute Inc
Organization:
EMD Serono
Organization Data
Organization:
EMD Serono
Class:
INDUSTRY
Study ID:
26593
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
EMD Serono Research Development Institute Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None